Translate Bio: Sanofi to Buy mRNA Developer: ETFs in Focus
Sanofi has agreed to acquire U.S. biotech company Translate Bio to gain exposure in the mRNA vaccine space.
Read full article »
CEO
Translate Bio is a Massachusetts-based biotechnology company that researches and develops mRNA therapeutics for the treatment of genetic diseases.
Read more